会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • DEVICE TO MONITOR GLUCOSE LEVELS AND ISCHEMIA
    • 监测葡萄糖水平和ISCHEMIA的装置
    • WO2009070675A2
    • 2009-06-04
    • PCT/US2008084863
    • 2008-11-26
    • MEDTRONIC INCBURNES JOHN EWARMAN EDUARDO N
    • BURNES JOHN EWARMAN EDUARDO N
    • G06F19/00
    • A61M5/1723A61M5/14244G06F19/3456
    • The disclosure relates to systems, methods, and devices for monitoring a patient's blood and cardiac condition. Patients with diabetes oftentimes wear diabetes management equipment (e.g., a glucose monitor, an external insulin pump, or a device having dual functionality). Such patients risk silent myocardial infarction. Herein described is regular cardiac ischemia/infarction monitoring - which if not monitored can lead to (silent) myocardial infarction. Moreover herein described are combined blood monitoring functionality and cardiac condition monitoring functionality via a single device, meaning that the patient is not required to wear additional equipment. Adding this functionality to already-existing equipment is significantly less invasive than requiring a patient to wear one piece of equipment to monitor his/her blood and a second piece of equipment to monitor his/her cardiac condition. This reduction in invasiveness can lead to significantly greater patient participation and compliance, which can improve health and save the lives of many patients.
    • 本公开涉及用于监测患者的血液和心脏状况的系统,方法和装置。 患有糖尿病的患者通常佩戴糖尿病管理设备(例如,葡萄糖监测器,外部胰岛素泵或具有双重功能的装置)。 这种患者存在无心肌梗塞的风险。 这里描述的是常规心脏缺血/梗死监测 - 如果不监测可导致(沉默)心肌梗死。 此外,这里描述的是通过单个装置组合的血液监测功能和心脏状态监测功能,这意味着患者不需要佩戴附加设备。 将此功能添加到已存在的设备中比要求患者佩戴一件设备来监测他/她的血液和第二件设备来监测他/她的心脏状况的侵入性要小得多。 这种侵袭性的降低可以导致患者参与和顺应性的显着增加,这可以改善健康并节省许多患者的生命。
    • 6. 发明申请
    • CARDIAC PACING METHOD AND SYSTEM
    • CARDIAC PACING方法和系统
    • WO03053513B1
    • 2004-04-08
    • PCT/US0241296
    • 2002-12-20
    • MEDTRONIC INC
    • HESS MICHAEL FWARMAN EDUARDO NBROWN MARK LMEHRA RAHULSHETH NIRAV VRITSCHER DAVID
    • A61N1/365A61N1/362A61N1/39
    • A61N1/3622A61N1/3624
    • AbstractThe invention relates to the use of atrial pacing therapies to treat atrial tachycardia (AT). When an AT episode is detected, an implantable medical device applies an ATP therapy. If the AT episode persists, the ATP therapy may be automatically reapplied at a later time during the course of the same AT episode. In particular, previously used ATP therapies are reapplied when episodic conditions, such as cycle length or cycle regularity, change. Although a particular ATP therapy initially may be unsuccessful in terminating the AT, it may prove successful when the cycle length or regularity of the atrial rhythm changes. As the rhythm slows down, the AT may be more responsive to ATP therapies that were previously unsuccessful. As a result, potentially efficacious ATP therapies can be reapplied to terminate AT episodes, and reduce the number of episodes that require more aggressive termination by painful, atrial shocks.
    • 摘要本发明涉及心房起搏疗法治疗房性心动过速(AT)的应用。 当检测到AT发作时,可植入医疗装置应用ATP疗法。 如果AT发作持续存在,ATP疗法可能会在相同的AT发作过程中的较晚时间自动重新应用。 特别是,当诸如循环长度或循环规律性等情况时,先前使用的ATP疗法将被重新应用。 尽管特定的ATP疗法最初可能不能终止AT,但是当心房节律的周期长度或规律性发生变化时,可能会成功。 随着节奏减慢,AT可能对以前不成功的ATP疗法更有反应。 因此,可以重新应用潜在有效的ATP疗法来终止AT发作,并通过痛苦的心房休克减少需要更积极终止的发作次数。